Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?

Autor:	Siebuhr, AS, Bay-Jensen, AC, Jordan, JM, Kjelgaard-Petersen, CF, Christiansen, C, Abramson, SB, Attur, M, Berenbaum, F, Kraus, V, Karsdal, MA
Předmět:	BONE diseases OSTEOARTHRITIS PROGNOSIS TREATMENT of arthritis BIOMARKERS ANTIRHEUMATIC agents ARTICULAR cartilage C-reactive protein INFLAMMATION MAGNETIC resonance imaging SYNOVIAL membranes SYNOVITIS
Zdroj:	Scandinavian Journal of Rheumatology; Mar2016, Vol. 45 Issue 2, p87-98, 12p
Abstrakt:	The disabling and painful disease osteoarthritis (OA) is the most common form of arthritis. Strong evidence suggests that a subpopulation of OA patients has a form of OA driven by inflammation. Consequently, understanding when inflammation is the driver of disease progression and which OA patients might benefit from anti-inflammatory treatment is a topic of intense research in the OA field. We have reviewed the current literature on OA, with an emphasis on inflammation in OA, biochemical markers of structural damage, and anti-inflammatory treatments for OA. The literature suggests that the OA patient population is diverse, consisting of several subpopulations, including one associated with inflammation. This inflammatory subpopulation may be identified by a combination of novel serological inflammatory biomarkers. Preliminary evidence from small clinical studies suggests that this subpopulation may benefit from anti-inflammatory treatment currently reserved for other inflammatory arthritides. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.